The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

AIMS: Patients with heart failure (HF) and iron deficiency experience poor health-related quality of life (HRQoL). We evaluated the impact of intravenous (IV) ferric carboxymaltose (FCM) vs. placebo on HRQoL for the AFFIRM-AHF population. METHODS AND RESULTS: The baseline 12-item Kansas City Cardiom...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankowska, Ewa A, Kirwan, Bridget-Anne, Kosiborod, Mikhail, Butler, Javed, Anker, Stefan D, McDonagh, Theresa, Dorobantu, Maria, Drozdz, Jarosław, Filippatos, Gerasimos, Keren, Andre, Khintibidze, Irakli, Kragten, Hans, Martinez, Felipe A, Metra, Marco, Milicic, Davor, Nicolau, José C, Ohlsson, Marcus, Parkhomenko, Alexander, Pascual-Figal, Domingo A, Ruschitzka, Frank, Sim, David, Skouri, Hadi, van der Meer, Peter, Lewis, Basil S, Comin-Colet, Josep, von Haehling, Stephan, Cohen-Solal, Alain, Danchin, Nicolas, Doehner, Wolfram, Dargie, Henry J, Motro, Michael, Friede, Tim, Fabien, Vincent, Dorigotti, Fabio, Pocock, Stuart, Ponikowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370759/
https://www.ncbi.nlm.nih.gov/pubmed/34080008
http://dx.doi.org/10.1093/eurheartj/ehab234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370759/
https://www.ncbi.nlm.nih.gov/pubmed/34080008
http://dx.doi.org/10.1093/eurheartj/ehab234

Ejemplares similares